Loading...
XNYSEHC
Market cap9.43bUSD
Dec 27, Last price  
93.59USD
1D
-0.79%
1Q
-2.52%
Jan 2017
126.94%
Name

Encompass Health Corp

Chart & Performance

D1W1MN
XNYS:EHC chart
P/E
26.79
P/S
1.96
EPS
3.49
Div Yield, %
0.64%
Shrs. gr., 5y
0.30%
Rev. gr., 5y
2.34%
Revenues
4.80b
+10.41%
3,753,781,0003,207,728,0003,000,100,0001,752,500,0001,842,400,0001,911,100,000520,700,0002,026,900,0002,134,900,0002,247,200,0002,374,300,0003,115,700,0003,646,000,0003,919,000,0004,277,300,0004,605,000,0004,644,400,0005,121,600,0004,348,600,0004,801,200,000
Net income
352m
+29.89%
-174,470,000-445,994,000-625,000,000653,400,000252,400,00094,800,000779,200,000208,700,000185,000,000323,600,000222,000,000183,100,000247,600,000256,300,000292,300,000358,700,000284,200,000412,200,000271,000,000352,000,000
CFO
851m
+20.54%
413,915,0001,561,000-120,400,000230,700,000227,200,000406,100,000331,000,000342,700,000411,500,000470,300,000444,900,000484,800,000605,500,000657,200,000762,400,000635,300,000704,700,000715,800,000705,800,000850,800,000
Dividend
Jan 02, 20250.17 USD/sh
Earnings
Feb 05, 2025

Profile

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families. As of June 1, 2022, it operated 149 hospitals, 252 home health locations, and 99 hospice locations in 42 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.
URL
https://www.encompasshealth.com/
IPO date
Sep 24, 1986
Employees
36,900
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
4,801,200
10.41%
4,348,600
-15.09%
5,121,600
10.27%
Cost of revenue
4,069,400
2,804,400
3,373,300
Unusual Expense (Income)
NOPBT
731,800
1,544,200
1,748,300
NOPBT Margin
15.24%
35.51%
34.14%
Operating Taxes
132,200
100,100
139,600
Tax Rate
18.07%
6.48%
7.98%
NOPAT
599,600
1,444,100
1,608,700
Net income
352,000
29.89%
271,000
-34.26%
412,200
45.04%
Dividends
(60,400)
(99,000)
(112,200)
Dividend yield
0.89%
1.65%
1.72%
Proceeds from repurchase of equity
(8,200)
BB yield
0.12%
Debt
Debt current
48,900
50,800
81,200
Long-term debt
3,076,100
3,166,800
3,708,500
Deferred revenue
28,000
Other long-term liabilities
205,900
174,200
173,200
Net debt
2,946,400
3,043,400
3,821,600
Cash flow
Cash from operating activities
850,800
705,800
715,800
CAPEX
(583,100)
(584,100)
(551,200)
Cash from investing activities
(602,800)
(627,000)
(666,300)
Cash from financing activities
(197,200)
(145,700)
(240,100)
FCF
289,500
1,164,700
1,108,800
Balance
Cash
69,100
21,800
54,800
Long term investments
109,500
152,400
(86,700)
Excess cash
Stockholders' equity
1,057,400
668,400
630,800
Invested Capital
5,365,300
5,028,400
6,110,600
ROIC
11.54%
25.93%
27.10%
ROCE
13.42%
30.21%
28.21%
EV
Common stock shares outstanding
101,300
100,400
100,200
Price
66.72
11.55%
59.81
-8.35%
65.26
-21.08%
Market cap
6,758,736
12.55%
6,004,924
-8.17%
6,539,052
-20.76%
EV
10,354,836
9,599,924
10,848,552
EBITDA
1,005,700
1,787,800
2,004,900
EV/EBITDA
10.30
5.37
5.41
Interest
143,500
175,700
164,600
Interest/NOPBT
19.61%
11.38%
9.41%